Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-386473

President, R&D sold 8,530 shares at $18.97 ($161,814)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-08 Sale : show line 1 in the form 10b5-1 −8,530 $18.97 $161,814 399,130 D
Open-market sales · 8,530 sh · avg $18.97 · $161,814
Loading xslF345X06/ownership.xml…